Angiogenesis in neuroblastoma:: Relationship to survival and other prognostic factors in a cohort of neuroblastoma patients

被引:44
|
作者
Cañete, A
Navarro, S
Bermúdez, J
Pellín, A
Castel, V
Llombart-Bosch, A
机构
[1] Hosp Infantil La Fe, Pediat Oncol Unit, Valencia 46009, Spain
[2] Univ Valencia, Dept Pathol, Sch Med, Valencia, Spain
[3] Univ Valencia, Dept Biostat, Valencia, Spain
关键词
D O I
10.1200/JCO.2000.18.1.27
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To study angiogenesis in neuroblastoma, using morphometric and computerized image analysis, and correlate the results with survival and other prognostic factors. Patients and Methods: Sixty-nine patients from the Spanish Cooperative Study for Neuroblastoma were studied. Tumoral angiogenesis was studied using an avidin-biotin immunoperoxidase technique with an anti-CD34 antibody. Vascular parameters (VPs) were analyzed by a computerized system. Statistical analysis wets also performed. Results: Sixty-six samples had adequate tumoral tissue, and their tumoral vessels were counted. Endothelial cells were more prominent in pure neuroblastomas than in maturing and more mature tumors. VPs showed no statistical difference between the groups of patients as defined by the levels of the other prognostic factors in neuroblastoma: age, stage, histopathology, TRK-A, p-glycoprotein expression, or MYCN copy number. In patients who relapsed, tumors did not show statistically significant difference in VPs when compared with tumors from patients who did not relapse. There was also no difference in VPs in tumors from living patients when compared with tumors from deceased patients. Overall survival was 75%, and event-free survival was 55% at 50 months. Conclusion: VPs could be adequately determined by a computerized system in neuroblastoma; however, VPs were not predictive of survival for our patients. In our patients, neither disseminated nor local relapses were influenced by the angiogenic characteristics of the tumors. (C) 2000 by American Society of Clinical Oncology.
引用
收藏
页码:27 / 34
页数:8
相关论文
共 50 条
  • [41] PROGNOSTIC VALUE OF ACUTE PHASE REACTANTS IN PATIENTS WITH NEUROBLASTOMA
    GERSON, J
    EVANS, AE
    ROSEN, FS
    [J]. CANCER, 1977, 40 (04) : 1655 - 1658
  • [42] Nucleolin expression has prognostic value in neuroblastoma patients
    Cangelosi, Davide
    Brignole, Chiara
    Bensa, Veronica
    Tamma, Roberto
    Malaguti, Fabiana
    Carlini, Barbara
    Giusto, Elena
    Calarco, Enzo
    Perri, Patrizia
    Ribatti, Domenico
    Fonseca, Nuno Andre
    Moreira, Joao Nuno
    Eva, Alessandra
    Amoroso, Loredana
    Conte, Massimo
    Garaventa, Alberto
    Sementa, Angela Rita
    Corrias, Maria Valeria
    Ponzoni, Mirco
    Pastorino, Fabio
    [J]. EBIOMEDICINE, 2022, 85
  • [43] Neuroblastoma in southern Africa: epidemiological features, prognostic factors and outcome
    Hesseling, PB
    Ankone, K
    Wessels, G
    Schneider, JW
    Du Plessis, L
    Moore, S
    [J]. ANNALS OF TROPICAL PAEDIATRICS, 1999, 19 (04): : 357 - 363
  • [44] MTHFR and VDR Polymorphisms Improve the Prognostic Value of MYCN Status on Overall Survival in Neuroblastoma Patients
    Olivera, Gladys G.
    Yanez, Yania
    Gargallo, Pablo
    Sendra, Luis
    Alino, Salvador F.
    Segura, Vanessa
    Angel Sanz, Miguel
    Canete, Adela
    Castel, Victoria
    Font De Mora, Jaime
    Hervas, David
    Berlanga, Pablo
    Jose Herrero, Maria
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (08)
  • [45] THE IMPACT OF SARCOPENIA AT DIAGNOSIS ON PROGNOSTIC OUTCOME IN PATIENTS WITH NEUROBLASTOMA
    Kudo, Wataru
    Terui, Keita
    Takenouchi, Ayako
    Komatsu, Shugo
    Oita, Satoru
    Yoshizawa, Hiroko
    Fumita, Takashi
    Nishimura, Katsuhiro
    Katsumi, Daisuke
    Hishiki, Tomoro
    [J]. PEDIATRIC BLOOD & CANCER, 2024, 71 : S14 - S14
  • [46] Prognostic impact of copy number variations in neuroblastoma patients
    Druy, Alexander
    Shorikov, Egor
    Tsaur, Grigory
    Tuponogov, Sergey
    Popov, Alexander
    Savellev, Leonid
    Fechlna, Larisa
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients
    Strenger, Volker
    Kerbl, Reinhold
    Dornbusch, Hans Juergen
    Ladenstein, Ruth
    Ambros, Peter F.
    Ambros, Inge M.
    Urban, Christian
    [J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (05) : 504 - 509
  • [48] FACTORS ASSOCIATED WITH RECURRENCE AND LENGTH OF SURVIVAL FOLLOWING RELAPSE IN PATIENTS WITH NEUROBLASTOMA: A PILOT STUDY
    Basta, Nermine
    Halliday, Gail
    Makin, Guy
    Feltbower, Richard
    Birch, Jillian
    Bown, Nick
    Elliott, Martin
    Ingham, Danielle
    Moreno, Lucas
    Barone, Giuseppe
    Pearson, Andrew
    James, Peter W.
    Tweddle, Deborah A.
    McNally, Richard J. Q.
    [J]. PEDIATRIC BLOOD & CANCER, 2012, 59 (06) : 1059 - 1059
  • [49] A 16-miRNA Prognostic Model to Predict Overall Survival in Neuroblastoma
    Wang, Jiepin
    Xiao, Dong
    Wang, Junxiang
    [J]. FRONTIERS IN GENETICS, 2022, 13
  • [50] SERUM CONCENTRATIONS AND GENETIC FACTORS IN NEUROBLASTOMA PATIENTS
    MORELL, A
    SKVARIL, F
    KASER, H
    SCHERZ, R
    [J]. SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1974, 104 (18) : 663 - 665